1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        Asia Pacific OTC Drug and Dietary Supplement Market – By Product

1.3.2        Asia Pacific OTC Drug and Dietary Supplement Market – By Type

1.3.3        Asia Pacific OTC Drug and Dietary Supplement Market – By Form

1.3.4        Asia Pacific OTC Drug and Dietary Supplement – By Distribution Channel

1.3.5        Asia Pacific OTC Drug and Dietary Supplement Market– By Region

2.           OTC Drug and Dietary Supplement Market – Key Takeaways

3.           Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           OTC Drug and Dietary Supplement – Market Landscape

4.1         Overview

4.2         PEST Analysis

4.2.1        Asia Pacific

4.3         Expert Opinion

5.           Asia Pacific OTC Drug and Dietary Supplement Market – Industry Dynamics

5.1         Market Drivers

5.1.1        Rising General Health Issues

5.1.2        Preference for OTC Drugs

5.2         Market Restraints

5.2.1        Stringent Government Regulations For OTC Drugs

5.3         Market Opportunities

5.3.1        Business Expansion Activities by Market Players to Offer Improved OTC Drugs

5.4         Future Trends

5.4.1        Preference of OTC Drugs for Minor Diseases

5.5         Impact Analysis

6.           OTC Drug and Dietary Supplement Market – Regional Analysis

6.1         Asia Pacific OTC Drug and Dietary Supplement Market Revenue Forecast And Analysis

7.           Asia Pacific OTC Drug and Dietary Supplement Market Analysis – By Product

7.1         Overview

7.2         OTC Drug and Dietary Supplement Revenue Share, by Product (2019 and 2027)

7.3         Cough and Cold Products

7.3.1        Overview

7.3.2        Cough and Cold Products: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027  (US$ Million)

7.4         Vitamins and Dietary Supplements

7.4.1        Overview

7.4.2        Vitamins and Dietary Supplements: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027  (US$ Million)

7.5         Analgesics

7.5.1        Overview

7.5.2        Analgesics: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)

7.6         Gastrointestinal Products

7.6.1        Overview

7.6.2        Gastrointestinal Products: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027  (US$ Million)

7.7         Sleep Aids

7.7.1        Overview

7.7.2        Sleep Aids: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)

7.8         Oral Care Products

7.8.1        Overview

7.8.2        Oral Care Products: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)

7.9         Ophthalmic Products

7.9.1        Overview

7.9.2        Ophthalmic Products: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)

7.10      Antacids

7.10.1     Overview

7.10.2     Antacids: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)

7.11      Feminine Care

7.11.1     Overview

7.11.2     Feminine Care: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)

7.12      Others

7.12.1     Overview

7.12.2     Others: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)

8.           OTC Drug and Dietary Supplement Analysis – By Type

8.1         Overview

8.2         OTC Drug and Dietary Supplement Revenue Share, by Type (2019 and 2027)

8.3         Branded

8.3.1        Overview

8.3.2        Branded: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)

8.4         Generic

8.4.1        Overview

8.4.2        Generic: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)

9.           OTC Drug and Dietary Supplement Analysis – By Form

9.1         Overview

9.2         OTC Drug and Dietary Supplement Share, by Form, 2019 and 2027, (%)

9.3         Tablets

9.3.1        Overview

9.3.2        Tablets: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)

9.4         Capsules

9.4.1        Overview

9.4.2        Capsules: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)

9.5         Powders

9.5.1        Overview

9.5.2        Powders: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)

9.6         Ointments

9.6.1        Overview

9.6.2        Ointments: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)

9.7         Liquid

9.7.1        Overview

9.7.2        Liquid: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)

9.8         Others

9.8.1        Overview

9.8.2        Others: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)

10.        OTC Drug and Dietary Supplement Analysis – By Distribution Channel

10.1      Overview

10.2      OTC Drug and Dietary Supplement Share, by Distribution Channel, 2019 and 2027, (%)

10.3      Hospital and Retail Pharmacies

10.3.1     Overview

10.3.2     Hospital and Retail Pharmacies: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)

10.4      Retail Stores

10.4.1     Overview

10.4.2     Retail Stores: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)

10.5      Online Channels

10.5.1     Overview

10.5.2     Online Channels: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)

10.6      Others

10.6.1     Overview

10.6.2     Others: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)

11.        OTC Drug and Dietary Supplement Analysis And Forecasts To 2027 – Geographical Analysis

11.1      Asia Pacific: OTC Drug and Dietary Supplement Market

11.1.1     Overview

11.1.2     Asia-Pacific: OTC Drug and Dietary Supplement Market,- Revenue and Forecast to 2027 (USD Million)

11.1.3     Asia-Pacific: OTC Drug and Dietary Supplement Market, by Product – Revenue and Forecast to 2027 (USD Million)

11.1.4     Asia-Pacific: OTC Drug and Dietary Supplement Market, by Type – Revenue and Forecast to 2027  (USD Million)

11.1.5     Asia-Pacific: OTC Drug and Dietary Supplement Market, by Form – Revenue and Forecast to 2027  (USD Million)

11.1.6     Asia-Pacific: OTC Drug and Dietary Supplement Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

11.1.7     Asia-Pacific: OTC Drug and Dietary Supplement Market, by Country, 2019 & 2027 (%)

11.1.8     China: OTC Drug and Dietary Supplement Market, – Revenue and Forecast to 2027 (USD Million)

11.1.8.1       China: OTC Drug and Dietary Supplement Market, – Revenue and Forecast to 2027 (USD Million)

11.1.8.2       China: OTC Drug and Dietary Supplement Market,, by Product – Revenue and Forecast to 2027 (USD Million)

11.1.8.3       China: OTC Drug and Dietary Supplement Market,, by Type – Revenue and Forecast to 2027 (USD Million)

11.1.8.4       China: OTC Drug and Dietary Supplement Market, by Form – Revenue and Forecast to 2027 (USD Million)

11.1.8.5       China: OTC Drug and Dietary Supplement Market, by Distribution Channel – Revenue and Forecast to 2027  (USD Million)

11.1.9     Japan: OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2027 (USD Million)

11.1.9.1       Japan: OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2027 (USD Million)

11.1.9.2       Japan: OTC Drug and Dietary Supplement Market, by Product – Revenue and Forecast to 2027 (USD Million)

11.1.9.3       Japan: OTC Drug and Dietary Supplement Market, by Type – Revenue and Forecast to 2027 (USD Million)

11.1.9.4       Japan: OTC Drug and Dietary Supplement Market, by Form – Revenue and Forecast to 2027 (USD Million)

11.1.9.5       Japan: OTC Drug and Dietary Supplement Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

11.1.10  India: OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2027 (USD Million)

11.1.10.1    India: OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2027 (USD Million)

11.1.10.2    India: OTC Drug and Dietary Supplement Market, by Product – Revenue and Forecast to 2027 (USD Million)

11.1.10.3    India: OTC Drug and Dietary Supplement Market, by Type – Revenue and Forecast to 2027 (USD Million)

11.1.10.4    India: OTC Drug and Dietary Supplement Market, by Form – Revenue and Forecast to 2027 (USD Million)

11.1.10.5    India: OTC Drug and Dietary Supplement Market, by Distribution Channel – Revenue and Forecast to 2027  (USD Million)

11.1.11  South Korea: OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2027 (USD Million)

11.1.11.1    South Korea: OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2027 (USD Million)

11.1.11.2    South Korea: OTC Drug and Dietary Supplement Market, by Product – Revenue and Forecast to 2027 (USD Million)

11.1.11.3    South Korea: OTC Drug and Dietary Supplement Market, by Type – Revenue and Forecast to 2027 (USD Million)

11.1.11.4    South Korea: OTC Drug and Dietary Supplement Market, by Form – Revenue and Forecast to 2027 (USD Million)

11.1.11.5    South Korea: OTC Drug and Dietary Supplement Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

11.1.12  Australia: OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2027 (USD Million)

11.1.12.1    Australia: OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2027 (USD Million)

11.1.12.2    Australia: OTC Drug and Dietary Supplement Market, by Product – Revenue and Forecast to 2027 (USD Million)

11.1.12.3    Australia: OTC Drug and Dietary Supplement Market, by Type – Revenue and Forecast to 2027 (USD Million)

11.1.12.4    Australia: OTC Drug and Dietary Supplement Market, by Form – Revenue and Forecast to 2027 (USD Million)

11.1.12.5    Australia: OTC Drug and Dietary Supplement Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

12.        Impact Of COVID-19 Pandemic On Global OTC Drug and Dietary Supplement Market

12.1      Asia Pacific: Impact Assessment of COVID-19 Pandemic

13.        Company Profiles

13.1      GlaxoSmithKline plc.

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2      Sanofi

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3      Johnson and Johnson Services, Inc.

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4      Abbott

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5      AbbVie Inc.

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

13.6      Bausch Health Companies Inc.

13.6.1     Key Facts

13.6.2     Business Description

13.6.3     Products and Services

13.6.4     Financial Overview

13.6.5     SWOT Analysis

13.6.6     Key Developments

13.7      Bayer AG

13.7.1     Key Facts

13.7.2     Business Description

13.7.3     Products and Services

13.7.4     Financial Overview

13.7.5     SWOT Analysis

13.7.6     Key Developments

13.8      Procter & Gamble

13.8.1     Key Facts

13.8.2     Business Description

13.8.3     Products and Services

13.8.4     Financial Overview

13.8.5     SWOT Analysis

13.8.6     Key Developments

13.9      Novartis AG

13.9.1     Key Facts

13.9.2     Business Description

13.9.3     Products and Services

13.9.4     Financial Overview

13.9.5     SWOT Analysis

13.9.6     Key Developments

13.10   Reckitt Benckiser Group Plc

13.10.1  Key Facts

13.10.2  Business Description

13.10.3  Products and Services

13.10.4  Financial Overview

13.10.5  SWOT Analysis

13.10.6  Key Developments

14.        Appendix

14.1      Glossary of Terms, OTC Drug and Dietary Supplement

Table 1.             Asia-Pacific: OTC Drug and Dietary Supplement Market, by Product – Revenue and Forecast to 2027  (USD Million)

Table 2.             Asia-Pacific: OTC Drug and Dietary Supplement Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 3.             Asia-Pacific: OTC Drug and Dietary Supplement Market, by Form – Revenue and Forecast to 2027 (USD Million)

Table 4.             Asia-Pacific: OTC Drug and Dietary Supplement Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 5.             China: OTC Drug and Dietary Supplement Market,, by Product – Revenue and Forecast to 2027 (USD Million)

Table 6.             China: OTC Drug and Dietary Supplement Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 7.             China: OTC Drug and Dietary Supplement Market, by Form – Revenue and Forecast to 2027 (USD Million)

Table 8.             China: OTC Drug and Dietary Supplement Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 9.             Japan: OTC Drug and Dietary Supplement Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 10.          Japan: OTC Drug and Dietary Supplement Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 11.          Japan: OTC Drug and Dietary Supplement Market, by Form – Revenue and Forecast to 2027 (USD Million)

Table 12.          Japan: OTC Drug and Dietary Supplement Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 13.          India: OTC Drug and Dietary Supplement Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 14.          India: OTC Drug and Dietary Supplement Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 15.          India: OTC Drug and Dietary Supplement Market, by Form – Revenue and Forecast to 2027 (USD Million)

Table 16.          India: OTC Drug and Dietary Supplement Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 17.          South Korea OTC Drug and Dietary Supplement Market, by Product – Revenue and Forecast to 2027  (USD Million)

Table 18.          South Korea OTC Drug and Dietary Supplement Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 19.          South Korea: OTC Drug and Dietary Supplement Market, by Form – Revenue and Forecast to 2027 (USD Million)

Table 20.          South Korea: OTC Drug and Dietary Supplement Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 21.          Australia: OTC Drug and Dietary Supplement Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 22.          Australia OTC Drug and Dietary Supplement Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 23.          Australia: OTC Drug and Dietary Supplement Market, by Form – Revenue and Forecast to 2027 (USD Million)

Table 24.          Australia: OTC Drug and Dietary Supplement Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Figure 1.           OTC Drug and Dietary Supplement Market Segmentation

Figure 2.           OTC Drug and Dietary Supplement Segmentation – By Region

Figure 3.           Asia Pacific OTC Drug and Dietary Supplement Market Overview

Figure 4.           Analgesics Segment Held Largest Share of OTC Drug and Dietary Supplement

Figure 5.           OTC Drug and Dietary Supplement Market in Germany to Show Remarkable Growth During Forecast Period

Figure 6.           Asia Pacific OTC Drug and Dietary Supplement Market- Leading Country Markets (US$ Million)

Figure 7.           Asia Pacific PEST Analysis

Figure 8.           OTC Drug and Dietary Supplement Impact Analysis Of Driver And Restraints

Figure 9.           Asia Pacific OTC Drug and Dietary Supplement Market – Revenue Forecast And Analysis – 2019- 2027

Figure 10.        OTC Drug and Dietary Supplement Revenue Share, by Product (2019 and 2027)

Figure 11.        Cough and Cold Products: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)

Figure 12.        Vitamins and Dietary Supplements: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027  (US$ Million)

Figure 13.        Analgesics: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)

Figure 14.        Gastrointestinal Products: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)

Figure 15.        Sleep Aids: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)

Figure 16.        Oral Care Products: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)

Figure 17.        Ophthalmic Products: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)

Figure 18.        Antacids: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)

Figure 19.        Feminine Care: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)

Figure 20.        Others: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)

Figure 21.        OTC Drug and Dietary Supplement Revenue Share, by Type (2019 and 2027)

Figure 22.        Branded: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)

Figure 23.        Generic: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)

Figure 24.        OTC Drug and Dietary Supplement Share, by Form, 2019 and 2027 (%)

Figure 25.        Tablets: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)

Figure 26.        Capsules: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)

Figure 27.        Powders: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)

Figure 28.        Ointments: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)

Figure 29.        Liquid: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)

Figure 30.        Others: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)

Figure 31.        OTC Drug and Dietary Supplement Share, by Distribution Channel, 2019 and 2027 (%)

Figure 32.        Hospital and Retail Pharmacies: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027  (US$ Million)

Figure 33.        Retail Stores: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)

Figure 34.        Online Channels: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)

Figure 35.        Others: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)

Figure 36.        Asia-Pacific: OTC Drug and Dietary Supplement Market, by Key Country – Revenue (2019) (USD Million)

Figure 37.        Asia-Pacific: OTC Drug and Dietary Supplement Market, Revenue and Forecast to 2027 (USD Million)

Figure 38.        Asia-Pacific: OTC Drug and Dietary Supplement Market, by Country, 2019 & 2027 (%)

Figure 39.        China: OTC Drug and Dietary Supplement Market, – Revenue and Forecast to 2027 (USD Million)

Figure 40.        Japan: OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2027 (USD Million)

Figure 41.        India: OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2027 (USD Million)

Figure 42.        South Korea: OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2027 (USD Million)

Figure 43.        Australia: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (USD Million)

Figure 44.        Impact of COVID-19 Pandemic on OTC Drug And Dietary Supplement Market in Asia Pacifican Countries